FotagliptinAlternative Names: Fotagliptin benzoate
Latest Information Update: 14 Apr 2016
At a glance
- Originator Chongqing Fochon Pharmaceutical
- Class Antihyperglycaemics
- Mechanism of Action CD26 antigen inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Type 2 diabetes mellitus